Find trials
Search tips

CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance

Overview

About this study

The purpose of this study is to assess whether use of  Continuous Glucose Monitoring (CGM) in patients with impaired glucose tolerance would Improve adherence to lifestyle modifications, resulting in improved insulin sensitivity as assessed using insulin sensitivity scores (ISS) from baseline to 6 months. Also, to assess insulin sensitivity using the QUICKI measure and will assess changes after just 3 months in both ISS and QUICKI. Additionally, to assess whether the same patients will have decreased body mass index from baseline to 6 months. We will also assess changes in BMI at 3 months and whether the same patients will have improved glucose tolerance as assessed by HbA1c and CGM data.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Rickey Carter, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20548288

Mayo Clinic Footer